“…Previous work using this method has shown support for the SMH (Gorka, Hedeker, Piasecki, & Mermelstein, 2017; Possemato et al., 2015). Epidemiological studies using general population samples can overcome some of the limitations of treatment‐seeking samples, such as treatment‐seeking bias, by being representative of the general population (Alegria et al., 2010; Crum, La Flair et al., 2013; Crum, Mojtabai et.al., 2013; Farmer et al., 2017; Feingold, Weiser, Rehm, & Lev‐ran, 2015, 2016; Fergusson, Boden, & Horwood, 2009; Kessler et al., 1997; Kuo, Gardner, Kendler, & Prescott, 2006; Lazareck et al., 2012; Liang, Chikritzhs, & Lenton, 2011; Martins et al., 2012; Martins, Keyes, Storr, Zhu, & Chilcoat, 2009; Menary, Kushner, Maurer, & Thuras, 2011; Robinson, Sareen, Cox, & Bolton, 2011; Sareen et al., 2001; Swendsen et al., 1998; Wolitzky‐Taylor, Bobova, Zinbarg, Mineka, & Craske, 2012). Epidemiological samples are further strengthened by using age of onset or longitudinal designs to assess the temporal onset of MD/AD and SUD.…”